August 29, 2017 — The far-reaching impact of the drug epidemic has elected officials and health experts working tirelessly to find effective methods to address the problem.
Philadelphia, its surrounding counties and the rest of the Delaware Valley has been one of the hardest-hit areas in the United States. While many factors contributed to the epidemic in the region, one Pennsylvania official wants to hold pharmaceutical companies accountable for their role in the opioid crisis.
State Treasurer Joe Torsella wrote an op-ed on philly.com to explain how this step could go a long way to curbing the crisis:
As Pennsylvania’s treasurer, my responsibilities include overseeing our state investments — your taxpayer dollars. These investments include Big Pharma companies, as the providers of the medicine and devices that our friends and neighbors need on a regular basis to survive.
Recently, I joined state treasurers from West Virginia and Illinois to demand that Big Pharma takes the necessary steps to combat the epidemic at its source. McKesson, located in San Francisco, is one of the nation’s largest prescription-drug wholesalers. While flooding communities with opioids, McKesson’s revenues have more than doubled from $93 billion to $199 billion over the past 10 years, with a $60 billion jump in 2015 alone.
These companies need to step forward and take active steps to address the growing challenges facing millions of prescription drug users across the nation.
Read the full story on philly.com.